Dengzhan Shengmai capsules and their active component scutellarin prevent cognitive decline in APP/PS1 mice by accelerating Aβ aggregation and reducing oligomers formation-Reference-Cited by-同舟云学术

Dengzhan Shengmai capsules and their active component scutellarin prevent cognitive decline in APP/PS1 mice by accelerating Aβ aggregation and reducing oligomers formation

Published:2020-01 Issue: Volume:121 Page:109682
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Zhang Shujuan,Zhang Jianxiang,Wei Dongfeng,An Haiting,Liu Wei,Lai Yihui,Yang Te,Shao Wen,Huang Yaping,Wang Lei,Dou Fei,Peng Dantao,Zhang Zhanjun

Funder

National Key R&D Program of China

State Key Program of National Natural Science of China

Beijing Municipal Science & Technology Commission

National Natural Science Foundation of China

China National Funds for Distinguished Young Scientists

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference53 articles.

1. NIA-AA research framework: toward a biological definition of Alzheimer’s disease;Jack;Alzheimer’s Dement.,2018

2. Spatial navigation deficits—overlooked cognitive marker for preclinical Alzheimer disease?;Coughlan;Nat. Rev. Neurol.,2018

3. A critical appraisal of amyloid-beta-targeting therapies for Alzheimer disease;Panza;Nat. Rev. Neurol.,2019

4. The amyloid hypothesis of Alzheimer’s disease at 25 years;Selkoe;EMBO Mol. Med.,2016

5. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective cohort study;Villemagne;Lancet Neurol.,2013

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological effects and the related mechanism of scutellarin on inflammation-related diseases: a review;Frontiers in Pharmacology;2024-08-12

2. Salvianic acid A sodium facilitates cardiac microvascular endothelial cell proliferation by enhancing the hypoxia‐inducible factor‐1 alpha/vascular endothelial growth factor signalling pathway post‐myocardial infarction;Clinical and Experimental Pharmacology and Physiology;2024-04-18

3. Altered synaptic currents, mitophagy, mitochondrial dynamics in Alzheimer's disease models and therapeutic potential of Dengzhan Shengmai Capsules intervention;Journal of Pharmaceutical Analysis;2023-10

4. Prebiotics modulate the microbiota–gut–brain axis and ameliorate cognitive impairment in APP/PS1 mice;European Journal of Nutrition;2023-07-17

5. A comprehensive perspective on the disposition, metabolism, and pharmacokinetics of representative multi-components of Dengzhan Shengmai in rats with chronic cerebral hypoperfusion after oral administration;Journal of Ethnopharmacology;2023-05